Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Sensitive and Cost-Effective Tools in the Detection of Ovarian Cancer Biomarkers Publisher



Elhami A1 ; Mobed A2 ; Soleimany R3 ; Yazdani Y4 ; Kazemi ES5 ; Mohammadi M6 ; Saffarfar H7
Authors
Show Affiliations
Authors Affiliations
  1. 1. Dentistry faculty, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
  2. 2. Social Determinants of Health Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
  3. 3. Faculty of Medicine, Imam Reza Hospital, Tabriz University of Medical Sciences, Tabriz, Iran
  4. 4. Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
  5. 5. Department of Obstetrics and Gynecology, Alzahra Hospital, Tabriz University of Medical Sciences, Tabriz, Iran
  6. 6. Student Research Committee, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  7. 7. Cardiovascular Research Center, Tehran, Tehran University of Medical Sciences, Tehran, Iran

Source: Analytical Science Advances Published:2024


Abstract

Women diagnosed with late-stage ovarian cancer suffer a very high rate of mortality. Accordingly, it is imperative to detect and diagnose the disease as early as possible in its development. Achievement of this aim implies relatively large-scale screening of women at an age of clinical significance through assay of biomarkers for disease present in blood or serum. Biosensor detection offers an attractive technology for the automated detection of such species. Among several biomarkers that have been identified that are present in patients with ovarian cancer, the only one that is commonly tested for in clinical use is cancer antigen 125, which is considered to be a poor biomarker for the disease. Here, we describe several biosensors that developed in the past decade for the detection of ovarian cancer biomarkers such as CA125, human epididymis protein 4 (HE4) and apolipoprotein A1. The challenges presented by the fabrication of biosensor devices for detecting ovarian cancer and the limited number of biosensors developed for this purpose are discussed. © 2024 The Author(s). Analytical Science Advances published by Wiley-VCH GmbH.
Related Docs
1. A Review on Polymeric Nanocomposites for the Electrochemical Sensing of Breast Cancer Biomarkers, Microchemical Journal (2023)
2. Beta-Glucans Is a Potential Inhibitor of Ovarian Cancer: Based on Molecular and Biological Aspects, Current Pharmaceutical Biotechnology (2022)
3. A Sensitive Aptamer-Based Biosensor for Electrochemical Quantification of Psa As a Specific Diagnostic Marker of Prostate Cancer, Journal of Pharmacy and Pharmaceutical Sciences (2020)
4. Biosensors; Nanomaterial-Based Methods in Diagnosing of Mycobacterium Tuberculosis, Journal of Clinical Tuberculosis and Other Mycobacterial Diseases (2024)
5. Ovarian Cancer Extracellular Vesicle Biomarkers, Clinica Chimica Acta (2025)
Experts (# of related papers)
View all Related Experts
Seyed Mohammad Akrami (1)
Mohammad Ali Mansournia (1)